Aliness ProbioBALANCE, Probiotic Bifidobacterium FORTE Balance, 60 capsules


Food supplement



1 capsule

2 capsules


20*10 9 cells

40*10 9 cells

   Bifidobacterium breve BR03

8*10 9 cells

16*10 9 cells

   Bifidobacterium animalis lactis BS01

6*10 9 cells

12*10 9 cells

   Bifidobacterium bifidum BB01

4*10 9 cells

8*10 9 cells

   Bifidobacterium infantis BI02

1*10 9 cells

2*10 9 cells

   Bifidobacterium longum BL03

1*10 9 cells

2*10 9 cells

 (1*10 9  cells =1 billion)

Ingredients: Bifidobacterium breve BR03, Bifidobacterium animalis lactis BS01, ifidobacterium bifidum BB01, Bifidobacterium infantis BI02, Bifidobacterium longum BL03, bacterial shell: glycerol esters of fatty acids, capsule shell (binding substance: hydroxypropyl methylcellulose).

ProbioBalance by Aliness® Bifidobacterium Balance contains a mix of five strains of bacteria from the Bifidobacterium family.

Recommended daily dose necessary to obtain the beneficial effect of the product: 1-2 capsules daily with a meal.


Do not exceed recommended servings for consumption during the day. A dietary supplement cannot be used as a substitute for a varied diet. A balanced diet and a healthy lifestyle are the basis for the proper functioning of the body.


The ProbioBalance by Aliness® Bifidobacterium FORTE Balance NO FOSS dietary supplement contains 20 billion bacteria in each capsule. Each bacterium has been covered with a double lipid layer, providing an effective barrier and allowing the bacteria to safely pass through the acidic environment of the stomach to reach the intestines intact, where it is to demonstrate its biological activity.


Storage conditions: The product can be stored at room conditions.

Refrigeration will extend shelf life. Temperatures above 25 °C should be avoided.

Keep out of the reach of small children.

In order to ensure the highest quality of the product throughout its expiration date, 20% technological allowance is added at the production stage, i.e. approximately 20% more bacteria to each capsule.

** The use of microencapsulated lactic acid bacteria requires a specific, patented analysis method, available from the manufacturer, to quantify viable bacterial cells (flow cytometry). Patent no. RM2009A000591

You may also like

Recently viewed